These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22525521)

  • 1. Examination of the carboxylesterase phenotype in human liver.
    Ross MK; Borazjani A; Wang R; Crow JA; Xie S
    Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
    Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
    Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.
    Crow JA; Herring KL; Xie S; Borazjani A; Potter PM; Ross MK
    Biochim Biophys Acta; 2010 Jan; 1801(1):31-41. PubMed ID: 19761868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Human Liver and Intestinal Carboxylesterases to the Hydrolysis of Selexipag In Vitro.
    Imai S; Ichikawa T; Sugiyama C; Nonaka K; Yamada T
    J Pharm Sci; 2019 Feb; 108(2):1027-1034. PubMed ID: 30267780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.
    Zhu HJ; Appel DI; Jiang Y; Markowitz JS
    Drug Metab Dispos; 2009 Sep; 37(9):1819-25. PubMed ID: 19487248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells.
    Shang W; Liu J; Chen R; Ning R; Xiong J; Liu W; Mao Z; Hu G; Yang J
    Xenobiotica; 2016; 46(5):393-405. PubMed ID: 26340669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alcohol on human carboxylesterase drug metabolism.
    Parker RB; Hu ZY; Meibohm B; Laizure SC
    Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny.
    Hines RN; Simpson PM; McCarver DG
    Drug Metab Dispos; 2016 Jul; 44(7):959-66. PubMed ID: 26825642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
    Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver.
    Sato Y; Miyashita A; Iwatsubo T; Usui T
    Drug Metab Dispos; 2012 May; 40(5):902-6. PubMed ID: 22293119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.
    Crow JA; Bittles V; Borazjani A; Potter PM; Ross MK
    Biochem Pharmacol; 2012 Nov; 84(9):1215-22. PubMed ID: 22943979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.
    Hatfield MJ; Tsurkan L; Hyatt JL; Yu X; Edwards CC; Hicks LD; Wadkins RM; Potter PM
    Br J Pharmacol; 2010 Aug; 160(8):1916-28. PubMed ID: 20649590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Hydrolase Activities in the Liver and Small Intestine between Marmosets and Humans.
    Honda S; Fukami T; Hirosawa K; Tsujiguchi T; Zhang Y; Nakano M; Uehara S; Uno Y; Yamazaki H; Nakajima M
    Drug Metab Dispos; 2021 Sep; 49(9):718-728. PubMed ID: 34135089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
    Laizure SC; Parker RB; Herring VL; Hu ZY
    Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.
    Boberg M; Vrana M; Mehrotra A; Pearce RE; Gaedigk A; Bhatt DK; Leeder JS; Prasad B
    Drug Metab Dispos; 2017 Feb; 45(2):216-223. PubMed ID: 27895113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?
    Xu J; Qiu JC; Ji X; Guo HL; Wang X; Zhang B; Wang T; Chen F
    Curr Drug Metab; 2019; 20(2):130-137. PubMed ID: 29600756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
    Thomsen R; Rasmussen HB; Linnet K;
    Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.